1. Home
  2. QTRX vs SCM Comparison

QTRX vs SCM Comparison

Compare QTRX & SCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QTRX
  • SCM
  • Stock Information
  • Founded
  • QTRX 2007
  • SCM 2012
  • Country
  • QTRX United States
  • SCM United States
  • Employees
  • QTRX N/A
  • SCM N/A
  • Industry
  • QTRX Biotechnology: Laboratory Analytical Instruments
  • SCM Finance/Investors Services
  • Sector
  • QTRX Industrials
  • SCM Finance
  • Exchange
  • QTRX Nasdaq
  • SCM Nasdaq
  • Market Cap
  • QTRX 439.1M
  • SCM 361.0M
  • IPO Year
  • QTRX 2017
  • SCM 2012
  • Fundamental
  • Price
  • QTRX $10.50
  • SCM $13.44
  • Analyst Decision
  • QTRX Strong Buy
  • SCM Hold
  • Analyst Count
  • QTRX 4
  • SCM 2
  • Target Price
  • QTRX $23.25
  • SCM $13.63
  • AVG Volume (30 Days)
  • QTRX 375.4K
  • SCM 169.5K
  • Earning Date
  • QTRX 11-12-2024
  • SCM 11-07-2024
  • Dividend Yield
  • QTRX N/A
  • SCM 11.91%
  • EPS Growth
  • QTRX N/A
  • SCM 307.51
  • EPS
  • QTRX N/A
  • SCM 1.96
  • Revenue
  • QTRX $129,330,000.00
  • SCM $107,143,385.00
  • Revenue This Year
  • QTRX $13.89
  • SCM $0.17
  • Revenue Next Year
  • QTRX $15.51
  • SCM N/A
  • P/E Ratio
  • QTRX N/A
  • SCM $6.86
  • Revenue Growth
  • QTRX 15.52
  • SCM 5.88
  • 52 Week Low
  • QTRX $9.87
  • SCM $12.48
  • 52 Week High
  • QTRX $29.70
  • SCM $14.68
  • Technical
  • Relative Strength Index (RSI)
  • QTRX 40.42
  • SCM 39.93
  • Support Level
  • QTRX $10.29
  • SCM $13.76
  • Resistance Level
  • QTRX $11.51
  • SCM $13.95
  • Average True Range (ATR)
  • QTRX 0.80
  • SCM 0.19
  • MACD
  • QTRX -0.13
  • SCM -0.05
  • Stochastic Oscillator
  • QTRX 20.10
  • SCM 38.55

About QTRX Quanterix Corporation

Quanterix Corp is a life sciences company. It focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory, Homebrew - Custom Assay Development, and Uman NF-Light.

About SCM Stellus Capital Investment Corporation

Stellus Capital Investment Corp is a closed-end, non-diversified management investment company. Its objective is to maximize the total return to its stockholders in the form of current income and capital appreciation. It invests in private middle-market companies through a first lien, second lien, and unsecured debt financing, often with a corresponding equity investment. The company invests in various sectors, such as business services, energy, general industrial, government services, healthcare, software, and specialty finance. Business activity of the firm is functioned through the United States and it generates revenue in the form of interest income on debt investments and capital gains and distributions.

Share on Social Networks: